Knowledge, no sign-up.
Atlas, questions, glossary and tools open to anyone doing research, with no account required to read or calculate.
FGX developed ELUCENIA, a global scientific mission to accelerate cancer research and understanding. The platform brings together an atlas of cancer types, the big questions in research, a glossary, sources and methods, and a hub of 228 tools, including calculators, scales and scores, in ten languages.
“Connect science. Move forward.”
Five areas of ELUCENIA, from the mission to the tools hub.
The home page introduces the mission and leads into the simulation and the research areas, in Portuguese, English and eight more languages.
01 / 05Cancer types, biological context and lines of investigation, with the sources and limits of each interpretation.
02 / 05149 calculators, 74 scales and scores, and 5 research tools, searchable by name, acronym or specialty.
03 / 05Open questions about cancer: what is known, what remains uncertain and what evidence is still missing.
04 / 05Concepts for following the research, linked to sources, questions and scientific contexts.
05 / 05A public, fast, multilingual platform that connects the people researching cancer.
Cancer types, biological context and lines of investigation, with the sources behind each interpretation.
228 tools with methods, units and limits in plain view, and no sign-up required to calculate.
Open questions organized by what is known and what is still missing.
Terms connected to sources, questions and methods.
The same content for researchers in different countries.
Every entry shows its review status and the sources that support the interpretation.
Atlas, questions, glossary and tools open to anyone doing research, with no account required to read or calculate.
Each interpretation shows where the information comes from and how far it holds.
Ten languages and pages ready for search engines and AI systems.
Content, tools and research connected in one fast, multilingual platform: tell us what your project needs to bring together.